Strong Association of De Novo Copy Number Mutations with Autism
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
We tested the hypothesis that de novo copy number variation (CNV) is associated with autism spectrum disorders (ASDs). We performed comparative genomic hybridization (CGH) on the genomic DNA of patients and unaffected subjects to detect copy number variants not present in their respective parents. Candidate genomic regions were validated by higher-resolution CGH, paternity testing, cytogenetics, fluorescence in situ hybridization, and microsatellite genotyping. Confirmed de novo CNVs were significantly associated with autism ( P = 0.0005). Such CNVs were identified in 12 out of 118 (10%) of patients with sporadic autism, in 2 out of 77 (3%) of patients with an affected first-degree relative, and in 2 out of 196 (1%) of controls. Most de novo CNVs were smaller than microscopic resolution. Affected genomic regions were highly heterogeneous and included mutations of single genes. These findings establish de novo germline mutation as a more significant risk factor for ASD than previously recognized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Accordingly, such CNVs must frequently occur as recurrent de novo mutations.”
From De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia (2012) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Collectively, these de novo heterozygous mutations are rare and confer relatively large risks of ASD 41 .”
From Autism spectrum disorder (2020) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CNVs and SNPs have both been reported to play a major role in autism incidence (36–41).”
From Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms (2014) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 45 ASD trios we detected and validated all 3 de novo CNVs that were identified in our previous study and in addition, we identified one novel de novo CNV 38 kb in size (Table S8).”
From High frequencies of de novo CNVs in bipolar disorder and schizophrenia (2011) · cites this paper as Sebat et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, a small set of autism spectrum disorder (ASD) trios (n = 45), all of which had been included in a previous study (Sebat et al., 2007) and three of which carried known de novo CNVs, were included as a “positive control” to confirm the sensitivity of our methods for detecting de novo events.”
From High frequencies of de novo CNVs in bipolar disorder and schizophrenia (2011) · cites this paper as Sebat et al., 2007
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892
Large-scale copy number polymorphism in the human genome
Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Månér, S., Massa, H., Walker, M., Chi, M., et al. (2004) · Science · doi:10.1126/science.1098918 · Cited by 2,557
Self-citationStructural variation in the human genome
Feuk, L., Carson, A. R., & Scherer, S. W. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1767 · Cited by 2,034
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Are Rare Variants Responsible for Susceptibility to Complex Diseases?
Pritchard, J. K. (2001) · The American Journal of Human Genetics · doi:10.1086/321272 · Cited by 1,197
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
Research works printed but not linked: 2
- E. Fombonne, J. Clin. Psychiatry66 (suppl. 10), 3 (2005).
- E. Orye, M. J. Delbeke, B. Vandenabeele, Lancet2, 1376 (1971).
Cited by
Items 301–400 of 1,022
The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function
Gehman, L. T., Meera, P., Stoilov, P., Shiue, L., O'Brien, J. E., Meisler, M. H., Ares, M., Otis, T. S., & Black, D. L. (2012) · Genes & Development · doi:10.1101/gad.182477.111 · Cited by 213
“Human mutations in the RBFOX1 (A2BP1) gene can lead to severe disorders, including mental retardation, epilepsy, and autism spectrum disorder (Bhalla et al. 2004; Barnby et al. 2005; Martin et al. 2007; Sebat et al. 2007; Voineagu et al. 2011).”
BackgroundSaha, S., Barnett, A. G., Foldi, C., Burne, T. H., Eyles, D. W., Buka, S. L., & McGrath, J. J. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000040 · Cited by 210
“The associations between APA and outcomes such as autism and schizophrenia are of particular interest, as these disorders have recently been associated with genomic structural variation [25–30].”
BackgroundPersonalized medicine: new genomics, old lessons
Offit, K. (2011) · Human Genetics · doi:10.1007/s00439-011-1028-3 · Cited by 203
“…germline copy number variation as a mechanism of susceptibility to autism, reviewed in this issue, was a hallmark early discovery of the genomics era (Sebat et al. 2007), and de novo point mutations have recently been observed in individuals affected by mental retardation (Vissers et al. 2010).”
BackgroundGenetic contributions to autism spectrum disorder
Havdahl, A., Niarchou, M., Starnawska, A., Uddin, M., van der Merwe, C., & Warrier, V. (2021) · Psychological Medicine · doi:10.1017/s0033291721000192 · Cited by 179
“A higher global frequency of de novo CNVs is observed in idiopathic autism cases from simplex families (10%) compared to multiplex families (2%) and controls (1%) (Halladay et al., 2015; Itsara et al., 2010; Sebat et al., 2007).”
BackgroundEstivill, X., & Armengol, L. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030190 · Cited by 210
Paternally inherited cis-regulatory structural variants are associated with autism
Brandler, W. M., Antaki, D., Gujral, M., Kleiber, M. L., Whitney, J., Maile, M. S., Hong, O., Chapman, T. R., Tan, S., Tandon, P., et al. (2018) · Science · doi:10.1126/science.aan2261 · Cited by 209
Self-citationGrarup, N., Sandholt, C. H., Hansen, T., & Pedersen, O. (2014) · Diabetologia · doi:10.1007/s00125-014-3270-4 · Cited by 201
“tions and point mutations are rare but high-impact risk factors in autism spectrum disorders [139, 140].”
BackgroundDuplication hotspots, rare genomic disorders, and common disease
Mefford, H. C., & Eichler, E. E. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.003 · Cited by 207
Fernandez, T. V., Sanders, S. J., Yurkiewicz, I. R., Ercan-Sencicek, A. G., Kim, Y.-S., Fishman, D. O., Raubeson, M. J., Song, Y., Yasuno, K., Ho, W. S. C., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.034 · Cited by 208
Hamilton, P. J., Campbell, N. G., Sharma, S., Erreger, K., Herborg Hansen, F., Saunders, C., Belovich, A. N., NIH ARRA Autism Sequencing Consortium, Daly, M. J., Gibbs, R. A., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.102 · Cited by 212
Self-citationLarge-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
Wang, T., Hoekzema, K., Vecchio, D., Wu, H., Sulovari, A., Coe, B. P., Gillentine, M. A., Wilfert, A. B., Perez-Jurado, L. A., Kvarnung, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18723-y · Cited by 206
Self-citationThe role of sex-differential biology in risk for autism spectrum disorder
Werling, D. M. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0112-8 · Cited by 208
Genetics and genomics of autism spectrum disorder: embracing complexity
De Rubeis, S., & Buxbaum, J. D. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv273 · Cited by 208
The array CGH and its clinical applications
Shinawi, M., & Cheung, S. W. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.06.007 · Cited by 200
Rosenfeld, J. A., Coppinger, J., Bejjani, B. A., Girirajan, S., Eichler, E. E., Shaffer, L. G., & Ballif, B. C. (2010) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9037-4 · Cited by 207
“Of the three AGRE multiplex families with affected children discordant for the 16p11.”
BackgroundInfluentialHu, V. W., Sarachana, T., Kim, K. S., Nguyen, A., Kulkarni, S., Steinberg, M. E., Luu, T., Lai, Y., & Lee, N. H. (2009) · Autism Research · doi:10.1002/aur.73 · Cited by 198
“…can be manifested by altered gene expression) as contributors to ASD are emphasized by recent studies, which show that copy number variants can be associated with both familial and spontaneous forms of ASD [Sebat et al., 2007; Szatmari, Paterson, Zwaigenbaum, Roberts, Brian, Liu et al., 2007b].”
BackgroundA Discovery Resource of Rare Copy Number Variations in Individuals with Autism Spectrum Disorder
Prasad, A., Merico, D., Thiruvahindrapuram, B., Wei, J., Lionel, A. C., Sato, D., Rickaby, J., Lu, C., Szatmari, P., Roberts, W., et al. (2012) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.112.004689 · Cited by 206
“CNV detection in case and control cohorts have been performed using several different microarray platforms, including those utilizing single-nucleotide polymorphisms (SNPs) and others using comparative genomic hybridization (CGH) arrays (Redon et al. 2006; Graubert et al. 2007; Christian et al.…”
MethodAntaki, D., Guevara, J., Maihofer, A. X., Klein, M., Gujral, M., Grove, J., Carey, C. E., Hong, O., Arranz, M. J., Hervas, A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01064-5 · Cited by 206
“Parental age effects are attributable to multiple mechanisms, including: (1) a de novo mutation mechanism (dnMIS, dnLoF) in which new mutations accumulate with age in the germline as fathers age28,41; (2) inherited rare-variants that directly contribute to parental age behavior in fathers, and; (3) a polygenic mechani…”
Self-citationThe functional impact of structural variation in humans
Hurles, M. E., Dermitzakis, E. T., & Tyler-Smith, C. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.03.001 · Cited by 205
Bassett, A. S., Scherer, S. W., & Brzustowicz, L. M. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09071016 · Cited by 205
Autism: A world changing too fast for a mis-wired brain?
Gepner, B., & Féron, F. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.006 · Cited by 191
“Finally, the metabotropic gl utamate receptor GRM8 in the chromosome 7q31-q33 autism susceptibility locus exhibits Linka ge Disequilibrium with autism (Serajee et al., 2003).”
Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder
Krupp, D. R., Barnard, R. A., Duffourd, Y., Evans, S. A., Mulqueen, R. M., Bernier, R., Rivière, J.-B., Fombonne, E., & O’Roak, B. J. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.07.016 · Cited by 204
Genetics of Congenital Heart Disease
A. Richards, A., & Garg, V. (2010) · Current Cardiology Reviews · doi:10.2174/157340310791162703 · Cited by 192
“Sebat and colleagues performed whole genome array CGH on subjects with autism spectrum disorders and their unaffected siblings and found that de novo but individually rare CNVs were significantly associated with autism [36].”
BackgroundThapar, A., & Rutter, M. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-020-04685-z · Cited by 168
Chow, M. L., Pramparo, T., Winn, M. E., Barnes, C. C., Li, H.-R., Weiss, L., Fan, J.-B., Murray, S., April, C., Belinson, H., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002592 · Cited by 202
“Additionally, although copy number variation (CNV) has been hypothesized to play an important role in the pathogenesis of autism [25,26] and may underlie important differences in gene expression, CNVs identified in brain tissue from individuals with autism have not been examined in relation to aberrant brain gene expr…”
BackgroundCopy Number and SNP Arrays in Clinical Diagnostics
Schaaf, C. P., Wiszniewska, J., & Beaudet, A. L. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-092010-110715 · Cited by 200
Hogart, A., Leung, K. N., Wang, N. J., Wu, D. J., Driscoll, J., Vallero, R. O., Schanen, N. C., & LaSalle, J. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061580 · Cited by 199
“Molecular investigation of gene expression in brain samples with extra copies of 15q11-13 provides insight into the potential complexities of other copy number variations in autism [33,34].”
BackgroundDistribution and functional impact of DNA copy number variation in the rat
Guryev, V., Saar, K., Adamovic, T., Verheul, M., van Heesch, S. A. A. C., Cook, S., Pravenec, M., Aitman, T., Jacob, H., Shull, J. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.141 · Cited by 197
Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens
Feng, J., Wilkinson, M., Liu, X., Purushothaman, I., Ferguson, D., Vialou, V., Maze, I., Shao, N., Kennedy, P., Koo, J., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-4-r65 · Cited by 198
“Mutations in the human A2BP1 gene have since been associated with several other neurological syndromes, including mental retardation, epilepsy, and autism spectrum disorders [54-57].”
BackgroundGenetic association analysis of copy-number variation (CNV) in human disease pathogenesis
Ionita-Laza, I., Rogers, A. J., Lange, C., Raby, B. A., & Lee, C. (2009) · Genomics · doi:10.1016/j.ygeno.2008.08.012 · Cited by 198
“In this study, the authors observed a disproportionate incidence of de novomutations in families with ASD (12 deletions and 2 duplications among affected families compared to 2 gains among controls).”
BackgroundInfluentialWalsh, C. A., Morrow, E. M., & Rubenstein, J. L. R. (2008) · Cell · doi:10.1016/j.cell.2008.10.015 · Cited by 196
“…Elsevier Inc. 397 One of the areas that has seen the most rapid recent progress in autism genetics has come with the realization that up to 7%–10% of children with autism have a variety of de novo chromosomal deletions and duplications (Sebat et al., 2007;Marshall et al., 2008; Kim et al., 2008).”
BackgroundImplications of gene copy-number variation in health and diseases
Almal, S. H., & Padh, H. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2011.108 · Cited by 188
Extending genome-wide association studies to copy-number variation
McCarroll, S. A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn282 · Cited by 199
Dosage sensitivity is a major determinant of human copy number variant pathogenicity
Rice, A. M., & McLysaght, A. (2017) · Nature Communications · doi:10.1038/ncomms14366 · Cited by 190
Genomic copy number variation, human health, and disease
Wain, L. V., Armour, J. A., & Tobin, M. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60249-x · Cited by 196
Rojas, D. C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1216-0 · Cited by 191
“Copy number variations (CNVs) are present in an additional 10 % of cases (Sebat et al. 2007).”
BackgroundDisruption at the PTCHD1 Locus on Xp22.11 in Autism Spectrum Disorder and Intellectual Disability
Noor, A., Whibley, A., Marshall, C. R., Gianakopoulos, P. J., Piton, A., Carson, A. R., Orlic-Milacic, M., Lionel, A. C., Sato, D., Pinto, D., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001267 · Cited by 193
Alaerts, K., Swinnen, S. P., & Wenderoth, N. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw027 · Cited by 193
“…level, the FPF view is supported by some recent reports showing that females with ASD display an increased genetic load compared to affected males (Sebat et al., 2007; Levy et al., 2011; Sanders et al., 2011) and that relatives of affected females with ASD are at an increased risk for ASD…”
BackgroundResultInfluentialIdring, S., Magnusson, C., Lundberg, M., Ek, M., Rai, D., Svensson, A. C., Dalman, C., Karlsson, H., & Lee, B. K. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt262 · Cited by 184
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 187
“Whole-exome sequencing and CNV analysis have uncovered rare de novo mutations in patients with ASD (147, 394).”
Autism genetics: searching for specificity and convergence
Berg, J. M., & Geschwind, D. H. (2012) · Genome Biology · doi:10.1186/gb-2012-13-7-247 · Cited by 192
“For example, whereas two studies report a higher number of de novo events in simplex than in multiplex families (10% simplex versus 3% multiplex [49] and 7% simplex versus 2% multiplex [51]), another reports an even distribution of de novo events across the two types of families (5.”
BackgroundResultInfluentialSelf-citationGenetics and Function of Neocortical GABAergic Interneurons in Neurodevelopmental Disorders
Rossignol, E. (2011) · Neural Plasticity · doi:10.1155/2011/649325 · Cited by 188
Genetic Variation, Comparative Genomics, and the Diagnosis of Disease
Eichler, E. E. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1809315 · Cited by 195
Griswold, A. J., Ma, D., Cukier, H. N., Nations, L. D., Schmidt, M. A., Chung, R.-H., Jaworski, J. M., Salyakina, D., Konidari, I., Whitehead, P. L., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds164 · Cited by 175
Risk of Autism and Increasing Maternal and Paternal Age in a Large North American Population
Grether, J. K., Anderson, M. C., Croen, L. A., Smith, D., & Windham, G. C. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp247 · Cited by 186
“It has been hypothesized that de novo mutations are associated with nonfamilial or sporadic autism (34), and limited evidence indicates that de novo copy number variations may be associated with autism in some children (35).”
BackgroundMilekic, M. H., Xin, Y., O’Donnell, A., Kumar, K. K., Bradley-Moore, M., Malaspina, D., Moore, H., Brunner, D., Ge, Y., Edwards, J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.84 · Cited by 190
Autism spectrum disorder in the genetics clinic: a review
Carter, M., & Scherer, S. (2013) · Clinical Genetics · doi:10.1111/cge.12101 · Cited by 174
“• The most common microscopically visible chromosome abnormalities (overall yield ∼2–5%) are idic(15), sex chromosome aneuploidy, and various large deletions and duplications • The most consistently reported submicroscopic chromosome abnormalities detected by chromosomal microarray (overall yield ∼10–20%) are recurren…”
BackgroundThe role of genetic variation in the causation of mental illness: an evolution-informed framework
Uher, R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.85 · Cited by 189
Betancur, C., & Buxbaum, J. D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-17 · Cited by 189
“[5] 165 1 de novo”
The Genetics of Microdeletion and Microduplication Syndromes: An Update
Watson, C. T., Tomas, M.-B., Sharp, A. J., & Mefford, H. C. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153408 · Cited by 183
“Chromosome microarray testing is a first-line test in the clinic for the diagnosis of patients with ID/DD, ASD, or multiple anomalies, and it has largely replaced traditional karyotype analysis (119).”
BackgroundResultInfluentialNGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment
Fernandez-Marmiesse, A., Gouveia, S., & Couce, M. L. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170718101946 · Cited by 180
“A review by Reiner et al. (2016) connected ASD and aberrant neuronal migration during brain development and discusses recent advancements in the field connecting ASD with brain morphogenesis disorders [72-73].”
InfluentialGrayton, H. M., Missler, M., Collier, D. A., & Fernandes, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067114 · Cited by 180
A decade of structural variants: description, history and methods to detect structural variation
Escaramís, G., Docampo, E., & Rabionet, R. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv014 · Cited by 169
“as was the case for the several variants involved in neurodevelopmental disorders [14, 18, 24, 25].”
BackgroundGenes, mutations, and human inherited disease at the dawn of the age of personalized genomics
Cooper, D. N., Chen, J.-M., Ball, E. V., Howells, K., Mort, M., Phillips, A. D., Chuzhanova, N., Krawczak, M., Kehrer-Sawatzki, H., & Stenson, P. D. (2010) · Human Mutation · doi:10.1002/humu.21260 · Cited by 183
“[2 00 3] HUMAN MUTATION, Vol. 31, No. 6, 631–655, 2010 641 et al., 2009; Glessner et al., 2009; Sebat et al., 2007; Stefansson et al., 2008; Walsh et al., 2008; Walters et al. 2010].”
The possible interplay of synaptic and clock genes in autism spectrum disorders
Bourgeron, T. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.020 · Cited by 185
The pursuit of genome-wide association studies: where are we now?
Ku, C. S., Loy, E. Y., Pawitan, Y., & Chia, K. S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.19 · Cited by 180
Hines, R. M., Wu, L., Hines, D. J., Steenland, H., Mansour, S., Dahlhaus, R., Singaraja, R. R., Cao, X., Sammler, E., Hormuzdi, S. G., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0032-08.2008 · Cited by 178
“In addition to single gene alterations, recent studies have shown that many autistic patients have novel deletions and duplications in their genomes (Sebat et al., 2007).”
BackgroundGenetics of schizophrenia: new findings and challenges
Gejman, P. V., Sanders, A. R., & Kendler, K. S. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101459 · Cited by 183
Gene and miRNA expression profiles in autism spectrum disorders
Ghahramani Seno, M. M., Hu, P., Gwadry, F. G., Pinto, D., Marshall, C. R., Casallo, G., & Scherer, S. W. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.046 · Cited by 177
Genetics evaluation for the etiologic diagnosis of autism spectrum disorders
Schaefer, G. B., & Mendelsohn, N. J. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31815efdd7 · Cited by 173
Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist
Lintas, C., & Persico, A. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060871 · Cited by 178
The Diverse Genetic Landscape of Neurodevelopmental Disorders
Hu, W. F., Chahrour, M. H., & Walsh, C. A. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025600 · Cited by 172
“Several recent studies have shown the importance of de novo copy-number variants (72, 100, 110, 117) and de novo point mutations in ASDs (7, 83, 87, 94–96, 111).”
BackgroundFrazier, T. W., Embacher, R., Tilot, A. K., Koenig, K., Mester, J., & Eng, C. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.125 · Cited by 177
“Full scale, verbal, and non-verbal IQ was significantly reduced in PTEN-ASD relative to other ASD groups and healthy controls (smallest Wald Χ2(3)=16.”
ResultTwo genetic variants of CD38 in subjects with autism spectrum disorder and controls
Munesue, T., Yokoyama, S., Nakamura, K., Anitha, A., Yamada, K., Hayashi, K., Asaka, T., Liu, H.-X., Jin, D., Koizumi, K., et al. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.03.004 · Cited by 177
Copy-number changes in evolution: rates, fitness effects and adaptive significance
Katju, V., & Bergthorsson, U. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00273 · Cited by 171
A 15q13.3 microdeletion segregating with autism
and the International Molecular Genetic Study of Autism Consortium (IMGSAC), Pagnamenta, A. T., Wing, K., Sadighi Akha, E., Knight, S. J., Bölte, S., Schmötzer, G., Duketis, E., Poustka, F., Klauck, S. M., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.228 · Cited by 174
Contact in the genetics of autism and schizophrenia
Burbach, J. P. H., & van der Zwaag, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.002 · Cited by 168
McEvoy, B. P., & Visscher, P. M. (2009) · Economics & Human Biology · doi:10.1016/j.ehb.2009.09.005 · Cited by 161
Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders
Schaaf, C. P., Sabo, A., Sakai, Y., Crosby, J., Muzny, D., Hawes, A., Lewis, L., Akbar, H., Varghese, R., Boerwinkle, E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr243 · Cited by 175
“These findings strengthen the role of FOXP2 and its contributions to the ASDs.”
BackgroundInfluentialDong, S., Walker, M. F., Carriero, N. J., DiCola, M., Willsey, A. J., Ye, A. Y., Waqar, Z., Gonzalez, L. E., Overton, J. D., Frahm, S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.068 · Cited by 170
“An excess of de novo copy number variants (CNVs) in affected individuals is well established (Levy et al., 2011; Sanders et al., 2011; Sebat et al., 2007).”
BackgroundIqbal, Z., Vandeweyer, G., van der Voet, M., Waryah, A. M., Zahoor, M. Y., Besseling, J. A., Roca, L. T., Vulto-van Silfhout, A. T., Nijhof, B., Kramer, J. M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt043 · Cited by 169
“De novo chromosomal aberrations leading to reduced ANK3 expression have been associated previously with an ASD phenotype and/or ADHD-like problems and/or developmental delay (55) (DECIPHER UPP001479 and AR256229, personal communication with Dr Vogel, Aarhus University Hospital).”
BackgroundGenetic and Epigenetic Etiology Underlying Autism Spectrum Disorder
Yoon, S., Choi, J., Lee, W., & Do, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040966 · Cited by 149
“17q12 Macrocephaly, neurocognitive impairment HNF1B Deletion [172] 20q13.”
Self-citationAccuracy of phenotyping of autistic children based on internet implemented parent report
Lee, H., Marvin, A. R., Watson, T., Piggot, J., Law, J. K., Law, P. A., Constantino, J. N., & Nelson, S. F. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31103 · Cited by 172
“Because of these shortcomings of ADOS, phenotyping for genetic studies rely primarily onADI-R supplemented byADOS [Sebat et al., 2007; Szatmari et al., 2007; Strom et al., 2009; Wang et al., 2009; Weiss et al., 2009].”
MethodOlsson, M., Meadows, J. R. S., Truvé, K., Rosengren Pielberg, G., Puppo, F., Mauceli, E., Quilez, J., Tonomura, N., Zanna, G., Docampo, M. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001332 · Cited by 168
“which are mainly benign and represent expansions or contractions of duplicated sequences [18].”
Human uniqueness: genome interactions with environment, behaviour and culture
Varki, A., Geschwind, D. H., & Eichler, E. E. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2428 · Cited by 167
Self-citationDisruptive insights in psychiatry: transforming a clinical discipline
Insel, T. R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38832 · Cited by 167
Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications
Yoo, H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.257 · Cited by 158
“The frequency of de novo CNVs in ASD has been reported as 3–19% in ASD from simplex and multiplex families, compared to approximately 1% in healthy controls [39-41].”
BackgroundPoultney, C. S., Goldberg, A. P., Drapeau, E., Kou, Y., Harony-Nicolas, H., Kajiwara, Y., De Rubeis, S., Durand, S., Stevens, C., Rehnström, K., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.001 · Cited by 169
“The Americ CNV, both inherited and de novo, has been repeatedly implicated in ASD, but for practical reasons the primary focus has been on CNV larger than 30 kb.(2,7,17,18) Whole-exome sequencing (WES) has emerged as a costeffective and efficient means to identify rare genic SNV contributing to risk for multiple disor…”
BackgroundRosenfeld, J. A., Ballif, B. C., Torchia, B. S., Sahoo, T., Ravnan, J. B., Schultz, R., Lamb, A., Bejjani, B. A., & Shaffer, L. G. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f0c5f3 · Cited by 169
Mikhail, F. M., Lose, E. J., Robin, N. H., Descartes, M. D., Rutledge, K. D., Rutledge, S. L., Korf, B. R., & Carroll, A. J. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34177 · Cited by 168
Bruno, D. L., Anderlid, B.-M., Lindstrand, A., van Ravenswaaij-Arts, C., Ganesamoorthy, D., Lundin, J., Martin, C. L., Douglas, J., Nowak, C., Adam, M. P., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.069906 · Cited by 165
Polygenic architecture of rare coding variation across 394,783 exomes
Weiner, D. J., Nadig, A., Jagadeesh, K. A., Dey, K. K., Neale, B. M., Robinson, E. B., Karczewski, K. J., & O’Connor, L. J. (2023) · Nature · doi:10.1038/s41586-022-05684-z · Cited by 165
Lesch, K.-P., Selch, S., Renner, T. J., Jacob, C., Nguyen, T. T., Hahn, T., Romanos, M., Walitza, S., Shoichet, S., Dempfle, A., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.29 · Cited by 167
Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167
The origins, determinants, and consequences of human mutations
Shendure, J., & Akey, J. M. (2015) · Science · doi:10.1126/science.aaa9119 · Cited by 162
Autism spectrum disorder: insights into convergent mechanisms from transcriptomics
Quesnel-Vallières, M., Weatheritt, R. J., Cordes, S. P., & Blencowe, B. J. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0066-2 · Cited by 162
Luo, R., Sanders, S. J., Tian, Y., Voineagu, I., Huang, N., Chu, S. H., Klei, L., Cai, C., Ou, J., Lowe, J. K., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.011 · Cited by 167
“The pathogenic role of de novo CNVs in ASDs has been previously established.(7,17,43,64,65) Although it has been assumed that underlying changes in gene expression contribute to pathogenicity, this has not been demonstrated previously.”
BackgroundSelf-citationThe Genetics of Autism: Key Issues, Recent Findings, and Clinical Implications
El-Fishawy, P., & State, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.002 · Cited by 166
“The first study to suggest this found that 7–10% of simplex autism families, 2 to 3% of multiplex families but only 1% of control families carried rare de novo CNVs.[55] Subsequent studies have supported this overall pattern.”
BackgroundAbel, H. J., & Duncavage, E. J. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.11.002 · Cited by 162
“Indels are common in the human genome and contribute to genetic diversity and human disease (47–49).”
BackgroundGenetic basis of human congenital anomalies of the kidney and urinary tract
Sanna-Cherchi, S., Westland, R., Ghiggeri, G. M., & Gharavi, A. G. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95300 · Cited by 160
“*The proportion of known genomic disorders in autism spectrum disorder is displayed as the weighted average of two independent studies (64, 65) Other manifestations include defects of the female internal genitalia and hypoparathyroidism; heart and ocular anomalies have occasionally been described…”
BackgroundVissers, L. E. L. M., de Vries, B. B. A., & Veltman, J. A. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.072942 · Cited by 160
Genetic advances in autism: heterogeneity and convergence on shared pathways
Bill, B. R., & Geschwind, D. H. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.004 · Cited by 164
“Recurrent CNVs at 15q11– 13 (1–3% of ASD patients), 16p11 ( 1% of ASD patients), and 22q11–13 [6 ,24 ,25,27,28] have been confirmed in multiple studies.”
Self-citationMitchell, M. M., Woods, R., Chi, L., Schmidt, R. J., Pessah, I. N., Kostyniak, P. J., & LaSalle, J. M. (2012) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21722 · Cited by 164
The Emerging Biology of Autism Spectrum Disorders
State, M. W., & Šestan, N. (2012) · Science · doi:10.1126/science.1224989 · Cited by 164
The genetics of neurodevelopmental disease
Mitchell, K. J. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.08.009 · Cited by 164
Depienne, C., Moreno‐De‐Luca, D., Héron, D., Bouteiller, D., Gennetier, A., Delorme, R., Chaste, P., Siffroi, J., Chantot‐Bastaraud, S., Benyahia, B., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.025 · Cited by 182
“Recent genome-wide studies of copy number variants in large ASD samples included an unknown proportion of patients who had been previously screened for chromosomal abnormalities and 15q11-q13 rearrangements (and excluded if positive), thus precluding the estimation of prevalence (5, 6).”
Next-Generation Treatments for Mental Disorders
Insel, T. R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004873 · Cited by 164
Expanding the range of ZNF804A variants conferring risk of psychosis
Steinberg, S., Mors, O., Børglum, A. D., Gustafsson, O., Werge, T., Mortensen, P. B., Andreassen, O. A., Sigurdsson, E., Thorgeirsson, T. E., Böttcher, Y., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.149 · Cited by 161
New and emerging approaches to treat psychiatric disorders
Scangos, K. W., State, M. W., Miller, A. H., Baker, J. T., & Williams, L. M. (2023) · Nature Medicine · doi:10.1038/s41591-022-02197-0 · Cited by 179
Brain connectivity in autism spectrum disorder
Mohammad-Rezazadeh, I., Frohlich, J., Loo, S. K., & Jeste, S. S. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000301 · Cited by 157
Metadata
- Authors
- Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., Leotta, A., Pai, D., Zhang, R., Lee, Y.-H., Hicks, J., Spence, S. J., Lee, A. T., Puura, K., Lehtimäki, T., Ledbetter, D., Gregersen, P. K., Bregman, J., Sutcliffe, J. S., Jobanputra, V., Chung, W., Warburton, D., King, M.-C., Skuse, D., Geschwind, D. H., Gilliam, T. C., Ye, K., & Wigler, M.
- Affiliations
- National Institutes of Health (US)
- Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
- Corresponding author
- Sebat, Jonathan
- Malhotra, Dheeraj
- Troge, Jennifer
- Wigler, Michael
- ORCID
- Venue
- Science
- Published
- 2007-04-20
- Volume
- 316
- Issue
- 5823
- Pages
- 445-449
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2993504
- OpenAlex
- W1971321176
- Semantic Scholar
- 39990d887387b14f6d8e6918b37c6f8ea93bf8ff
- Cited by
- 2,795
- References
- 33
- Citations by year
- 2026: 34 · 2025: 58 · 2024: 55 · 2023: 70 · 2022: 90 · 2021: 126 · 2020: 129 · 2019: 109 · 2018: 105 · 2017: 114 · 2016: 130 · 2015: 183 · 2014: 168 · 2013: 217 · 2012: 226
- FWCI
- 132.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of Mental Health (R01MH061009, MH076431, MH 61009, MH 64547, R01MH064547, R01MH076431)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- de novo copy number variation, autism spectrum disorder, germline mutations, genetic risk factors, chromosomal abnormalities, candidate genomic regions
- MeSH terms
- Autistic Disorder, Child, Female, Humans, Male, Markov Chains, Mutation, Nucleic Acid Hybridization, Parents, Genome, Human, Case-Control Studies, Gene Deletion, In Situ Hybridization, Fluorescence, Germ-Line Mutation, Gene Dosage, Microsatellite Repeats, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Gene Duplication, Cytogenetic Analysis, Asperger Syndrome, Siblings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.